For keeping essential medications flowing
Source: Fast Company
As a manufacturer of active pharmaceutical ingredients (APIs) and finished pharmaceutical products, Phlow is on a mission to improve the U.S. medicine supply chain. In 2021, as it continued to deliver on a four-year, $354 million contract with the Biomedical Advanced Research and Development Authority to provide APIs and essential drugs during the pandemic, Phlow brought 11 leading children’s hospitals together to create the Children’s Hospital Coalition. Through the coalition, Phlow—which uses a speedier and yield-focused “continuous flow” process for manufacturing its APIs (basically allowing chemical reactions to run on a smaller scale continually)—will ensure supply and affordability of certain medications. Phlow is also focused on building a national stockpile of APIs to prepare for a public health emergency.